Qube Research & Technologies (QRT)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13M Sell
180,500
-73,900
-29% -$5.69M 0.01% 1126
2025
Q4
$20.2M Buy
254,400
+83,600
+49% +$6.59M 0.02% 906
2025
Q3
$12.9M Sell
170,800
-153,700
-47% -$10.5M 0.01% 1163
2025
Q2
$22.4M Sell
324,500
-86,800
-21% -$5.69M 0.02% 815
2025
Q1
$27.9M Buy
411,300
+261,100
+174% +$15.6M 0.03% 603
2024
Q4
$6.74M Buy
150,200
+121,900
+431% +$6.84M 0.01% 1328
2024
Q3
$1.78M Sell
28,300
-2,400
-8% -$140K ﹤0.01% 1801
2024
Q2
$1.81M Buy
30,700
+26,100
+567% +$1.63M ﹤0.01% 1683
2024
Q1
$367K Buy
+4,600
New +$351K ﹤0.01% 2706

Other funds holding CVS

Qube Research & Technologies (QRT)'s CVS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its CVS Health (CVS) stake by 32% in Q1 2026, buying an estimated $39.8M and bringing the position to 2,150,366 shares worth $154M. The position accounts for 0.17% of the portfolio, ranked #126.

Qube Research & Technologies (QRT) first reported a position in CVS in Q1 2018 and has held it in 25 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Qube Research & Technologies (QRT) held 2,150,366 shares of CVS Health worth $154M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 516,220 CVS Health shares in Q1 2026, an estimated $39.8M.
  • CVS Health made up 0.17% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #126 holding.
  • Qube Research & Technologies (QRT) first reported a position in CVS Health in Q1 2018 and has held it in 25 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.